Andrew Turner
Andrew Turner
Verified email at
TitleCited byYear
Capitalizing hope: the commercial development of umbilical cord blood stem cell banking
P Martin, N Brown, A Turner
New genetics and society 27 (2), 127-143, 2008
DataSHIELD: taking the analysis to the data, not the data to the analysis
A Gaye, Y Marcon, J Isaeva, P LaFlamme, A Turner, EM Jones, J Minion, ...
International journal of epidemiology 43 (6), 1929-1944, 2014
Fracking on YouTube: Exploring risks, benefits and human values
R Jaspal, A Turner, B Nerlich
Environmental Values 23 (5), 501-527, 2014
Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy
W Pearce, S Raman, A Turner
Trials 16 (1), 394, 2015
DataSHIELD: An Ethically Robust Solution to Multiple-Site Individual-Level Data Analysis
I Budin-Ljøsne, P Burton, J Isaeva, A Gaye, A Turner, M M.J, W S, F V, ...
Public Health Genomics 18 (2), 87-96, 2015
‘Placebos’ and the logic of placebo comparison
A Turner
Biology and Philosophy 27 (3), 419-432, 2012
The Commercial Development of Cell Therapy—Lessons for the Future
P Martin, R Hawksley, A Turner
Survey of the cell therapy industry and the main products in use and …, 2009
International Data Sharing in Practice: New Technologies Meet Old Governance
MJ Murtagh, A Turner, JT Minion, M Fay, PR Burton
Biopreservation and biobanking 14 (3), 231-240, 2016
DataSHIELD–new directions and dimensions
RC Wilson, OW Butters, D Avraam, J Baker, JA Tedds, A Turner, ...
Data Science Journal 16 (21), 1-21, 2017
Biobank Economics and the “Commercialization Problem”
A Turner, C Dallaire-Fortier, MJ Murtagh
Spontaneous Generations: A Journal for the History and Philosophy of Science …, 2013
Problematic placebos in physical therapy trials
M Maddocks, R Kerry, A Turner, J Howick
Journal of Evaluation in Clinical Practice, 2016
The ECOUTER methodology for stakeholder engagement in translational research
MJ Murtagh, JT Minion, A Turner, RC Wilson, M Blell, C Ochieng, ...
BMC Medical Ethics 18 (1), 24, 2017
Evaluating the UK House of Commons Science and Technology Committee’s position on the implausible effectiveness of homeopathic treatments
A Turner
Theoretical Medicine and Bioethics 38 (4), 335-352, 2017
Digital methodology to implement the ECOUTER engagement process
RC Wilson, OW Butters, T Clark, J Minion, A Turner, MJ Murtagh
F1000Research 5, 2016
Exploratory evaluation of variation in statin take up among high risk patients in Nottingham City
A Turner, I Shaw
Public health 10 (127), 958-960, 2013
What Are the Benefits of a New Placebo Language?
A Turner
Perspectives in Biology and Medicine 61 (3), 401-411, 2018
Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project
J Gallacher, F de Reydet de Vulpillieres, B Amzal, Z Angehrn, C Bexelius, ...
Journal of Alzheimer's Disease, 1-7, 2019
Stakeholder views about participating in paediatric biobanks: a narrative review
CA OCHIENG, J Minion, A Turner, M Murtagh
International Journal of Humanities and Social Sciences 2 (1), 2015
Response to Miles and Mezzich
A Turner, J Blakey, R Kerry
European Journal for Person Centered Healthcare 2 (1), 83-84, 2014
Evidence-based medicine, "placebos" and the homeopathy controversy
AJ Turner
University of Nottingham, 2012
The system can't perform the operation now. Try again later.
Articles 1–20